The value of chromosome 8 heteroploid tumor cells in the peripheral blood and pleural effusion in evaluating treatment efficacy and the prognosis of metastatic non-small cell lung cancer patients

The results suggest that CTC counts and their chromosomal features could serve as significant prognostic indicators for predicting treatment responses in NSCLC. Future studies with larger patient cohorts need to be conducted to validate these findings and assess the feasibility of using CTC analyses as routine clinical instruments. This approach could ultimately contribute to the development of personalized treatment plans for the effective management of NSCLC.